What does intangible asset and IP valuation for Chinese and Japanese investors in the UAE cover? It is an independent fair value estimate of patents, technology, brands and customer relationships, prepared to IVS and IFRS 3 with a reconciliation to CAS or J-GAAP reporting where needed. It supports joint venture contributions, technology and brand valuation, and purchase price allocation. Corvian Advisory provides it from Dubai as UAE-based valuation advice for Chinese and Japanese investors and China and Japan-linked transactions, through a CFA-led team with 15+ years of Big 4 experience. Fixed fee from CNY 30,000, typically 3–6 weeks.
Independent, IVS-aligned and IFRS 3-compliant valuation of intangible assets for Chinese and Japanese corporates entering the UAE by acquisition or joint venture. Manufacturing know-how, patents and robotics or electronics technology are common themes, and every report is signed by CFA, CA and ACCA qualified practitioners.
A CFA Charterholder and Chartered Accountant with Big 4 experience leads each engagement. Reports are documented line by line, so a parent's finance team and auditors can follow each assumption.
Chinese and Japanese-linked mandates tend to be technology and process heavy, so we invest time in understanding what is patented, what is know-how and what would be hard to replace.
Corvian Advisory provides UAE-based valuation advice to Chinese and Japanese investors and on China and Japan-linked transactions, prepared to IVS and IFRS 3. We are not registered valuers in China and Japan. Where a statutory or regulatory valuation specific to China and Japan is required, we work alongside a locally authorised valuer and coordinate our analysis with theirs.
For technology and manufacturing IP we separate what is protected by patent from what is know-how, then test how long each advantage would last.
Royalties avoided by owning a patent, technology or brand, benchmarked against Asian and international licence data and tested against margin capacity.
Attributes cash flow to technology and customer relationships after charges for contributory assets, typical for manufacturing and electronics.
Cost to recreate process know-how, software and tooling, adjusted for obsolescence and used as a floor value.
Remaining Useful Life Analysis
Royalty-relief and excess earnings analysis with useful-life testing.
Cost and income methods for unpatented process knowledge.
Royalty-relief valuation for licensing into the Middle East and Africa.
Attrition-based excess earnings for distributors and OEM customers.
Risk-adjusted valuation of development-stage technology.
Fair value of IP contributed by each partner.
China and Japan-linked mandates cluster in industrial technology, electronics, energy equipment and consumer brands.
| Sector | Primary Approach | Key Value Driver |
|---|---|---|
| Industrial Automation & Robotics | Relief-from-royalty, MPEEM | Patent life, service revenue |
| Electronics | Relief-from-royalty | Product cycle length, licensing |
| Clean Energy Equipment | MPEEM, cost | Technology life, offtake |
| Automotive Components | Relief-from-royalty, MPEEM | OEM relationships, tooling |
| Consumer Brands | Relief-from-royalty | Brand pull, channel reach |
| Medical Devices | MPEEM | Product approvals, service contracts |
Every engagement starts with a fixed-scope proposal agreed and signed before work begins. Fees are quoted in CNY, JPY or USD, with no hourly billing.
One intangible class, one primary method, with rate benchmarking.
All identifiable intangibles at fair value, with IFRS 3 documentation and a reconciliation to CAS or J-GAAP where needed.
Analysis of IP held or licensed between related entities, benchmarked to OECD-aligned principles.
A call on the transaction, the technology involved and the parent's reporting standards. Fixed fee agreed upfront.
Identify recognisable intangibles and collect patents, process documentation, customer contracts and R&D records.
Method selection per asset, royalty and attrition analysis, technology-life assessment and sensitivities.
A walkthrough of the draft valuation with your finance team and auditors before finalising.
Signed report with methodology, assumptions, useful-life analysis and sensitivities, prepared to IVS and consistent with IFRS 13 and IFRS 3.
Answers to what China and Japan-linked groups ask before commissioning an IP valuation.
Share the outline and we will confirm a fixed fee within one business day.